IP Library › Granted Patent US 10,927,258
Granted Patent B2
US 10,927,258 · App. 16/471,999 · Granted Feb 23, 2021

Process for the preparation of Indigotindisulfonate sodium (indigo carmine)

Inventors: Manik Reddy Pullagurla (Hyderabad, IN); Jagadeesh Babu Rangisetty (Hyderabad, IN)
Assignee: BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.
C09B7/02C09B67/0025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,927,258
App. No.
16/471,999
Granted
Feb 23, 2021
Kind
B2
Abstract

This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation.

Claims (19)

1. An improved process for the preparation of Indigotindisulfonate sodium having purity greater than 99.0% comprising the steps of:

i. treating a 2-nitrobenzaldehyde (2)

 with base to give a 2,2′-biindolylidene-3,3′-dione (3);

ii. sulphonating the 2,2′-biindolylidene-3,3′-dione (3) by treating with concentrated sulphuric acid followed by pH adjustment with sodium hydroxide to obtain crude Indigotindisulfonate sodium (1); and

iii. purifying the crude Indigotindisulfonate sodium (1) to give pure Indigotindisulfonate sodium (1), wherein the purification process comprises:

a. suspending crude Indigotindisulfonate sodium (1) in protic or aprotic solvent;

b. heating the suspension to 60-65° C.;

c. cooling the suspension to 20-25° C.; and

d. filtering the suspension and washing with methanol at 20-25° C. to isolate pure crystalline Indigotindisulfonate sodium (1).

2. The process as claimed in claim 1 , wherein the base used in step i) is selected from the group consisting of sodium hydroxide, sodium carbonate, sodium bicarbonate or the like.

3. The process as claimed in claim 1 , wherein the pH in step ii) is maintained above 13 by using sodium hydroxide.

4. The process as claimed in claim 1 , wherein the protic or aprotic solvent is selected from the group consisting of water, methanol, ethanol, isopropanol, n-butanol, acetonitrile, tetrahydrofuran, acetone, ethyl acetate, dichloromethane or mixtures thereof.

5. A process for the purification of Indigotindisulfonate sodium comprising:

a. suspending crude Indigotindisulfonate sodium (1) in protic or aprotic solvent;

b. heating the suspension to 60-65° C.;

c. cooling the suspension to 20-25° C.; and

d. filtering the suspension and washing with methanol at 20-25° C. to isolate pure crystalline Indigotindisulfonate sodium (1).

6. The process as claimed in claim 5 , wherein the protic or aprotic solvent is selected from the group consisting of water, methanol, ethanol, isopropanol, n-butanol, acetonitrile, tetrahydrofuran, acetone, ethyl acetate, dichloromethane or mixtures thereof.

7. A crystalline form I of Indigotindisulfonate sodium wherein X-ray powder diffraction (XRPD) pattern as shown in FIG. 1 having peaks at 2 theta values 5.8, 11.67, 15.37, 17.62, 20.31 and 26.54±0.2°

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.
To: PROVEPHARM LIFE SOLUTIONS S.A.
Reel/Frame 061568/0216 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: PULLAGURLA, MANIK REDDY; RANGISETTY, JAGADEESH BABU
To: BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.,
Reel/Frame 051048/0981 →
Priority Claims (1)
IN 201641044154 · Dec 23, 2016 · national
Continuity (1)
Related Publication 20200017689A1 · Jan 16, 2020